Remove 2025 Remove Leads Remove Training
article thumbnail

Adopting AI for R&D in 2025 – what needs to be addressed?

European Pharmaceutical Review

For] AI use in life sciences R&D… 2025 will see the industry enter the “plateau of enlightenment” AI use in life sciences R&D has now passed through most major stages of the Gartner Hype Cycle 2 and 2025 will see the industry enter the “plateau of enlightenment.” Computers in Biology and Medicine.

article thumbnail

10 Best Sales Intelligence Tools For 2025

Spotio

In 2025, your success will depend on your ability to collect and analyze critical data. After extensive research, including reviews of real user feedback, weve compiled a comprehensive list of the top 10 sales intelligence tools for 2025. Key Features: Lead Generation: Use 200+ filters to identify high-quality leads.

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How You Should Be Training While Building a Remote Sales Team

Quantified

Video and phone calls and emails don’t immediately lend themselves as well as in-person visits when it comes to building trust and relationships, yet most salespeople have little training as to how to adjust their techniques to accommodate a different interaction. What’s the Role of AI in Sales Training, Learning & Development?

article thumbnail

AbbVie Cork facility €60 million expansion

European Pharmaceutical Review

The €60 million expansion will open 70 new jobs in sterile manufacturing, quality control and engineering in 2025. A three-year employee training programme, backed by the government and the IDA (a funding support agency), will help its 150 employees develop essential skills when using innovative, upcoming technologies.

article thumbnail

Oligonucleotide manufacturing centre to open in Scotland

European Pharmaceutical Review

For example, CPI asserted that lead times for clinical trial materials are hindering new therapies being developed. The Oligonucleotide Manufacturing Innovation Centre of Excellence will also facilitate “a highly skilled workforce” to be trained and development to accelerate access of these medicines to patients, CPI noted.

article thumbnail

Amgen and Pfizer appoint new Science executives

European Pharmaceutical Review

Dr Boshoff will begin this new role on 1 January 2025 and will oversee all R&D functions across every therapeutic area in the company. He trained as medical oncologist at the Royal Marsden and Royal Free Hospitals in London. Furthermore, Dr Roger Dansey will become Interim Chief Oncology Officer, from 1 January 2025.

article thumbnail

A Shift in Medical Affairs Amid the Challenge of Data Management and Rise of AI

PM360

According to a report by McKinsey & Company, the medical affairs function is on track to rise in importance, becoming the third strategic pillar alongside the research and development (R&D) and commercial functions by 2025. This lack of understanding may lead to resistance or wariness of new technology. Regulatory concerns.